Geez, brutal day for Arcturus Therapeutics, investors dumped shares on the market and there weren't too many buyers interested in picking them up which causes price to plunge. Negative outlook for the company may continue to
hammer the stock. We'll see if we hit bottom here and get some buyers to come in fishing for value.
It looks like Arcturus Therapeutics isn't currently at a very decisive point in regards to support/resistance levels. Arcturus Therapeutics hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the Biotechnology company has lost -22.41 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. ARCT might find some support at the 33.03 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Arcturus Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 7.51. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. William Blair reiterated a rating of Outperform on 2024-03-08. On 2024-02-08 Citigroup increased their price target by 20% to $48.00. Canaccord Genuity Group initiated a rating of Buy on 2023-12-13. On 2023-11-28 HC Wainwright reiterated their rating of Buy and added a price target of $51.00. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-08-22 and they set their price target at $54.00. Wells Fargo & Company boosted their price targ by 28.57% to $45.00 on 2023-07-17. Guggenheim reiterated a rating of Buy on 2023-07-14.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
ARCT | 7.51 | 10.68 | 0 | 4.34 | 0 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
ARCT | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
ARCT | 17.98 | %20.6 | 13.6 | 8.118 | 4990000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | 0.79 | -3.72 | -2.26 | -0.85 | 7.67 | 40.04 | 55.08 | 6.66 | 6.30 | 3.43 | -14013.76 | -12974.30 | 16.84 | 4.74 | 9.36 | 8.41 |
Healthcare | 230 | 0.88 | -1.52 | -0.30 | -2.16 | 5.72 | 27.64 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.55 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
ARCT |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT | Editas Medicine, Inc. Com | 1.13 | -2.82 | -13.00 | -24.21 | -34.51 | -58.66 | -76.19 | 47 | -172.46 | -138.74 | -176.20 | -57394.91 | 2.09 | 0 | 0 | 16.4101 |
TWST | Twist Bioscience Corporat | 1.05 | -0.51 | 5.52 | 2.16 | -6.93 | -0.60 | 73.39 | 57 | 1.93 | 4.07 | 3.73 | 178.09 | -19226.76 | 0 | 0 | 23.3961 |
NVAX | Novavax Inc | 1 | 0.75 | 11.63 | -18.75 | -27.58 | -46.80 | 50.65 | 23 | -7.16 | -5.43 | 1.69 | -5296.36 | -9552.39 | 0 | 150 | 23.8911 |
VCYT | Veracyte, Inc. | 0.98 | 0.13 | 5.83 | 19.59 | 23.97 | 88.10 | 55.68 | 75 | 87.77 | 54.07 | 28.48 | 0.00 | -24528.43 | 150 | 0 | 4.97884 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.